NEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced with great sadness the passing of longtime Board Member, William J. Kennedy, PhD. “It is with ...

Ether inhaler, c. 1846, developed by William T.G. Morton. While many toyed with anesthetic agents, it was Morton who first developed a novel delivery instrument to enable ether inhalation during ...

Approved in February of 2021, TG Therapeutics’ first-in-class drug Ukoniq was billed as a potentially safer treatment for lymphoma patients. But 16 months later, the FDA has rescinded its ...